These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 6642096)

  • 1. Clinical importance of the reversible fraction of haemoglobin A1c in Type 2 (non-insulin-dependent) diabetes.
    Jury DR; Baker JR; Dunn PJ
    Diabetologia; 1983 Oct; 25(4):313-5. PubMed ID: 6642096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling cost effectiveness of insulin glargine for the treatment of type 1 and 2 diabetes in Canada.
    Grima DT; Thompson MF; Sauriol L
    Pharmacoeconomics; 2007; 25(3):253-66. PubMed ID: 17335310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical usefulness of glucated haemoglobin in diabetes care evaluated by use of a medical technology assessment strategy.
    Larsen ML
    Dan Med Bull; 1997 Jun; 44(3):303-15. PubMed ID: 9233549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should haemoglobin A1C be used for diagnosis of diabetes mellitus in Malawi?
    Nakanga WP; Crampin A; Nyirenda M
    Malawi Med J; 2016 Mar; 28(1):28-30. PubMed ID: 27217915
    [No Abstract]   [Full Text] [Related]  

  • 5. Glycated albumin and glycated hemoglobin are influenced differently by endogenous insulin secretion in patients with type 2 diabetes.
    Koga M; Murai J; Saito H; Kasayama S
    Diabetes Care; 2010 Feb; 33(2):270-2. PubMed ID: 19846794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylated haemoglobin and steady-state mean blood glucose concentration in Type 1 (insulin-dependent) diabetes.
    Svendsen PA; Lauritzen T; Søegaard U; Nerup J
    Diabetologia; 1982 Nov; 23(5):403-5. PubMed ID: 6757030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Random blood glucose estimation in type 2 diabetes: does it reflect overall glycaemic control?
    Gill GV; Hardy KJ; Patrick AW; Masterson A
    Diabet Med; 1994; 11(7):705-8. PubMed ID: 7955999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycated haemoglobin; past, present, and future are we ready for the change.
    Syed IA
    J Pak Med Assoc; 2011 Apr; 61(4):383-8. PubMed ID: 21465979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosylated haemoglobin and blood glucose levels in Libyan diabetic patients.
    Rao GM; Morghom LO; Abukhris AA; Mansori SS; Alphgih FA; Ragale LY
    Trop Geogr Med; 1986 Dec; 38(4):391-7. PubMed ID: 3810843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in glycaemic control with rosiglitazone/metformin fixed-dose combination therapy in patients with type 2 diabetes with very poor glycaemic control.
    Rosenstock J; Rood J; Cobitz A; Huang C; Garber A
    Diabetes Obes Metab; 2006 Nov; 8(6):643-9. PubMed ID: 17026488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mean and variability of annual haemoglobin A1c are associated with high-risk peripheral artery disease.
    Lee IT
    Diab Vasc Dis Res; 2020; 17(3):1479164120909030. PubMed ID: 32148085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of blood glucose concentration on labile A1c in diabetic patients.
    Kawahara R; Amemiya T; Komori T; Hirata Y
    Diabetes Care; 1985; 8(4):375-9. PubMed ID: 4042804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glargine insulin/gliclazide MR combination therapy is more effective than premixed insulin monotherapy in Chinese patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs.
    Zhou J; Zheng F; Guo X; Yang H; Zhang M; Tian H; Guo L; Li Q; Mo Y; Jia W
    Diabetes Metab Res Rev; 2015 Oct; 31(7):725-33. PubMed ID: 25952634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of short-term iPRO continuous glucose monitoring on hemoglobin A1c levels in clinical practice.
    Pepper GM; Steinsapir J; Reynolds K
    Diabetes Technol Ther; 2012 Aug; 14(8):654-7. PubMed ID: 22690923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of Internet intervention on 926 patients with diabetes mellitus for up to 30 months.
    Tildesley HD; Conway ME; Deng L; Lee AM; Chan JH; Mazanderani AB; Tildesley HG; White AS; Pawlowska M; Ross SA
    Can J Diabetes; 2015 Jun; 39(3):216-20. PubMed ID: 25623618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic control in children with insulin dependent diabetes mellitus assessed by hemoglobin A1c.
    Mortensen HB; Vestermark S; Kastrup KW
    Acta Paediatr Scand; 1982 Mar; 71(2):217-22. PubMed ID: 6753471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on glycosylated plasma proteins in diabetic patients.
    Rehman J; Rahman MA
    J Pak Med Assoc; 1991 Jan; 41(1):16-8. PubMed ID: 1900545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Measurement of Haemoglobin A1c by isoelectric focussing in diabetic patients.
    Stickland MH; Perkins CM; Wales JK
    Diabetologia; 1982 May; 22(5):315-7. PubMed ID: 7047279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Multicenter Real-Life Study on the Effect of Flash Glucose Monitoring on Glycemic Control in Patients with Type 1 and Type 2 Diabetes.
    Anjana RM; Kesavadev J; Neeta D; Tiwaskar M; Pradeepa R; Jebarani S; Thangamani S; Sastry NG; Brijendra Kumar S; Ramu M; Gupta PPK; Vignesh J; Chandru S; Kayalvizhi S; Jagdish PS; Uthra SCB; Lovelena M; Jyoti S; Suguna Priya S; Kannan A; Mohan V; Unnikrishnan R
    Diabetes Technol Ther; 2017 Sep; 19(9):533-540. PubMed ID: 28930495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of metabolic control in patients with diabetes treated with insulin using Contour USB and A1cNow+ devices (COMET study).
    Vinagre I; Álvarez P; García N; Roura G; Conget I;
    Endocrinol Nutr; 2015 Oct; 62(8):384-90. PubMed ID: 26391507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.